INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 130 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,595,648 | +61.4% | 193,940 | -3.7% | 0.02% | +61.5% |
| Q2 2023 | $2,228,148 | -2.4% | 201,460 | +21.9% | 0.01% | -18.8% |
| Q2 2022 | $2,283,000 | -14.6% | 165,310 | +0.7% | 0.02% | 0.0% |
| Q1 2022 | $2,672,000 | +0.4% | 164,210 | +0.5% | 0.02% | +6.7% |
| Q4 2021 | $2,662,000 | +8487.1% | 163,385 | +81592.5% | 0.02% | +1400.0% |
| Q4 2014 | $31,000 | -86.9% | 200 | -80.0% | 0.00% | -90.0% |
| Q3 2014 | $237,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |